Goosehead Insurance shares fell $8.56, or 15.6%, after the company announced on November 9, 2026, that financial statements for fiscal years 2023-2025 and interim 2026 periods must be restated. The firm is currently reassessing internal controls following an SEC comment letter, prompting Hagens Berman to launch an investigation into potential securities-law violations regarding commission and franchisee fee accounting.
Goosehead announced on November 9, 2026 it will not timely file its Q3 report and that financial statements for fiscal 2023-2025 and interim periods in 2026 must be restated, while it reassesses internal controls after an SEC comment letter. The shares already fell $8.56 (-15.6%) the next day, and a securities-law investigation by Hagens Berman adds further litigation and credibility risk. Restatement scope, control doubts and possible SEC enforcement argue for continued pressure.
- ▼ November 9, 2026 disclosure that financial statements for FY2023, FY2024, FY2025 and 2026 interim periods should no longer be relied upon and must be restated
- ▼ Delayed quarterly report for the period ended September 30, 2026
- ▲ The 15.6% share-price drop may already reflect much of the restatement news
- ▲ The investigation is preliminary and no charges or enforcement action have been filed